Financing round completed
Qvanteq AG completed a financing round. It provides the company with sufficient cash to further develop its technology for vascular stents such as intracranial stents and flow diverters.
Category: 2017
Qvanteq’s technology in peer-reviewed journals
In vivo data involving Qvanteq’s surface technology was published in the April issue of the journal Eurointervention.